Welltower Inc. (WELL)
NYSE: WELL
· Real-Time Price · USD
149.17
2.27 (1.55%)
At close: May 23, 2025, 3:59 PM
150.52
0.91%
After-hours: May 23, 2025, 05:59 PM EDT
Welltower Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|
| Senior Housing - Operating Revenue | 6.04B | 751.15M | 556.81M | n/a | n/a | n/a |
| Senior Housing - Operating Revenue Growth | +703.49% | +34.90% | n/a | n/a | n/a | n/a |
| Outpatient Medical Revenue | 802.11M | 4.77B | 900.96M | n/a | n/a | n/a |
| Outpatient Medical Revenue Growth | -83.20% | +429.84% | n/a | n/a | n/a | n/a |
| Triple Net Revenue | 788.77M | 1.04B | n/a | n/a | n/a | n/a |
| Triple Net Revenue Growth | -24.40% | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Canada Revenue | 554.56M | 509.31M | 458.89M | 422.76M | 434.41M | 463.12M | 469.58M |
| Canada Revenue Growth | +8.88% | +10.99% | +8.55% | -2.68% | -6.20% | -1.38% | n/a |
| United States Revenue | 6.56B | 5.52B | 4.84B | 3.77B | 3.72B | 4.21B | 3.78B |
| United States Revenue Growth | +18.87% | +14.01% | +28.58% | +1.25% | -11.54% | +11.32% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 63.76M | 48.71M | 77.9M | 55.56M | 53.32M | 44.33M | 46.11M | 44.29M | 44.37M | 41.32M | 34.81M | 36.55M | 37.71M | 33.11M | 32.26M | 31.44M | 29.93M | 27.85M | 31M | 34.06M | 35.48M | 26.51M | 31.02M | 33.74M | 35.28M | 31.1M | 28.75M | 32.83M | 33.7M | 28.36M | 29.91M | 32.63M | 31.1M | 32.81M | 36.83M | 39.91M | 45.69M | 36.85M | 36.95M | 38.47M | 35.14M |
| Selling, General, and Administrative Revenue Growth | +30.90% | -37.48% | +40.20% | +4.21% | +20.28% | -3.86% | +4.11% | -0.19% | +7.39% | +18.70% | -4.77% | -3.06% | +13.88% | +2.64% | +2.61% | +5.05% | +7.46% | -10.18% | -8.98% | -4.00% | +33.86% | -14.55% | -8.07% | -4.37% | +13.44% | +8.19% | -12.44% | -2.59% | +18.83% | -5.18% | -8.33% | +4.92% | -5.20% | -10.92% | -7.73% | -12.64% | +23.98% | -0.26% | -3.96% | +9.49% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |